12-64488572-GAAA-GAA
Variant names:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_013254.4(TBK1):c.1432delA(p.Thr478LeufsTer2) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,448,646 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as other (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
TBK1
NM_013254.4 frameshift
NM_013254.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.65
Genes affected
TBK1 (HGNC:11584): (TANK binding kinase 1) The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. The protein is also an important kinase for antiviral innate immunity response. [provided by RefSeq, Sep 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.1432delA | p.Thr478LeufsTer2 | frameshift_variant | Exon 12 of 21 | ENST00000331710.10 | NP_037386.1 | |
TBK1 | XM_005268809.2 | c.1432delA | p.Thr478LeufsTer2 | frameshift_variant | Exon 12 of 21 | XP_005268866.1 | ||
TBK1 | XM_005268810.2 | c.1432delA | p.Thr478LeufsTer2 | frameshift_variant | Exon 12 of 21 | XP_005268867.1 | ||
TBK1 | XR_007063071.1 | n.1531delA | non_coding_transcript_exon_variant | Exon 12 of 18 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1448646Hom.: 0 Cov.: 28 AF XY: 0.00000139 AC XY: 1AN XY: 719926
GnomAD4 exome
AF:
AC:
3
AN:
1448646
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
719926
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: other
Submissions summary: Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Motor neuron disease Other:1
Aug 31, 2016
Centre for Genomic and Experimental Medicine, University of Edinburgh
Significance: other
Review Status: criteria provided, single submitter
Collection Method: case-control
Loss-of-function but lacking segregation data Loss-of-function
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at